Study of ZIO-101 in Multiple Myeloma

Completed · Phase 1/Phase 2

Conditions studied: Multiple Myeloma

In brief

The study of safety of a new organic arsenic compound in the treatment of advanced multiple myeloma

Key facts

Study ID

NCT00303199

Run by

Alaunos Therapeutics

People needed

35

Starts

2006-01-01

Expected to finish

2007-08-01

Last updated by the study team

2012-07-19

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Study site — Little Rock, Arkansas, United States
• Study site — West Hollywood, California, United States
• Study site — Miami, Florida, United States
• Study site — Bethesda, Maryland, United States
• Study site — New York, New York, United States
• Study site — Cleveland, Ohio, United States
• Study site — Edmonton, Alberta, Canada
• Study site — Toronto, Ontario, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.